Trustmark National Bank Trust Department Bristol Myers Squibb CO Transaction History
Trustmark National Bank Trust Department
- $1.34 Billion
- Q4 2024
A detailed history of Trustmark National Bank Trust Department transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Trustmark National Bank Trust Department holds 56,315 shares of BMY stock, worth $3.14 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
56,315
Previous 38,370
46.77%
Holding current value
$3.14 Million
Previous $1.99 Million
60.45%
% of portfolio
0.24%
Previous 0.15%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...